HayMax, maker of the organic drug-free allergen barrier balm, has announced its win in the M&A Today Global Awards 2024 in the category of Leading Pharmaceutical Company.
With participation from over 163 countries, the Awards ‘celebrate unparalleled excellence globally’. Haymax’s achievement signifies the company’s ‘dedication and strategic innovation in the industry’, setting it apart as a global leader.
The Awards involve a rigorous selection process that involves both an assessments stage and a judging stage, and are ‘renowned for their thorough and objective selection process, ensuring the recognition of truly exceptional firms’.
“We are delighted to receive this global award,” comments HayMax MD Max Wiseberg, “as recognition of our innovative product and expansion into overseas markets from our traditional UK base. This is a great achievement for a small company to win on a global scale.”
HayMax is the original natural, organic, drug-free prevention for hay fever sufferers, and works differently from most other hay fever treatments and remedies. It works on the prevention principle by seeking to stop pollen getting into the body before it can cause a reaction, rather than attempting to treat the symptoms or the effect of the pollen once they occur.
